West Pharma (WST) Declares $0.14 Quarterly Dividend, 0.6% Yield; Announces Up to 800K Share Buyback Program

Go back to West Pharma (WST) Declares $0.14 Quarterly Dividend, 0.6% Yield; Announces Up to 800K Share Buyback Program

West Pharma (WST) Tops Q4 EPS by 1c, Slight Miss on Revenues

February 15, 2018 6:02 AM EST

West Pharma (NYSE: WST) reported Q4 EPS of $0.64, $0.01 better than the analyst estimate of $0.63. Revenue for the quarter came in at $415.6 million versus the consensus estimate of $416.58 million.

Executive Summary

Fourth-quarter 2017 reported net sales of $415.6 million grew 8.7% over the prior-year quarter. At constant currency, organic sales growth was 4.5%. Excluding impacts from the deconsolidation of operations in Venezuela and hurricane-related shutdowns, organic sales growth would have been 6.0%.Full-year 2017... More